Dr. Scherzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Brigham and Women's Hospital, Harvard Medical School
60 Fenwood Road
Boston, MA 02115
Summary
- Solve Parkinson's disease with precision neurology
www.scherzerlaboratory.org
Education & Training
Emory University School of MedicineResidency, Neurology, 1998 - 2001- Emory University School of MedicineInternship, Transitional Year, 1997 - 1998
University of Vienna Faculty of MedicineClass of 1995
Certifications & Licensure
CT State Medical License 2024 - 2025
MA State Medical License 2003 - 2024- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 193 citationsGenome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architectureRuth Chia, Marya S. Sabir, Sara Bandres-Ciga, Sara Saez-Atienzar, Regina H. Reynolds
Nature Genetics. 2021-02-15 - 292 citationsβ2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseShuchi Mittal, Kjetil Bjornevik, Doo Soon Im, Adrian Flierl, Xianjun Dong
Science. 2017-09-01 - 197 citationsParkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresMansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, Ruth Padmore, Youren Tong
Journal of Neural Transmission. 2011-05-07
Journal Articles
- PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's diseaseZheng, B. Liao, Z. Locascio, J. J. Lesniak, K. A. Roderick, S. S. Watt, M. L. Eklund, A. C. Zhang-James, Y. Kim, P. D. Hauser, M. A. Grunblatt, E. Moran, L. B. Mandel,..., Science Translational Medicine, 2010
Press Mentions
Precision Medicine for Parkinson’s: New Yale Center for Advanced ResearchOctober 14th, 2024- Parkinson's Disease Could Have 3 Subtypes, Researchers FindJuly 23rd, 2024
- Study Uncovers Genetic Variants Linked to Disease ProgressionMay 10th, 2021
- Join now to see all
Grant Support
- Risk Marker For Parkinson'S Disease: Enabling Novel TherapiesNational Institute Of Neurological Disorders And Stroke2008–2011
- Genomic Markers Of Disease Progression In Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke2008
- Multigene Marker Of Progression In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2008
- Genomic And Genetic Analysis Of Parkinson'S DiseaseNational Institute On Aging2004–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
